DBV Technologies (DBVT) Change in Intangibles (2020)

DBV Technologies (DBVT) reported Change in Intangibles of $9000.0 for Q4 2020, little changed quarter-over-quarter from $9000.0 in Q3 2020.

DBV Technologies (DBVT) Change in Intangibles (2020) Analysis & Trends

DBV Technologies (DBVT) has 1 years of Change in Intangibles data on file, last reported at $9000.0 in Q4 2020.

Change in Intangibles for Q4 2020 came in at $9000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $9000.0 (changed N/A YoY), and the FY2025 annual result was $6000.0, up 100.0% from the prior year.
Change in Intangibles steadied at $9000.0 in Q4 2020 per DBVT's latest filing, from $9000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $114000.0 in Q1 2020 and troughed at -$103000.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-2.96 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	DBV Technologies	6.63 Bn	6.41 Bn	-3.90 Mn	-

Download Data